RecruitingGestational DiabetesDiabetes Mellitus, Type 2
DETERMINE: Detemir vs NPH
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.
Sponsor: University of California, Los Angeles
You may qualify if…
- ✓ Inclusion criteria will include pregnant women with pre-existing T2DM and GDM who requiring insulin to manage their blood sugars in pregnancy.
You may not qualify if…
- ✕ 1. Multiple Gestation
- ✕ 2. Type 1 Diabetes mellatus
- ✕ 3. Age \< 18
- ✕ 4. Known or suspected hypersensitivity to NPH or insulin detemir
- ✕ 5. Known fetal major malformations
- ✕ 6. Chronic renal or hepatic insufficiency
- ✕ 7. Known to be HIV, Hepatitis B, or Hepatitis C positive
- ✕ 8. Indication for planned premature delivery (placenta accrete, or prior classical cesarean delivery)
Where it's recruiting
California
Los Angeles
Source: ClinicalTrials.gov · NCT05124457 · last updated 2023-09-26